Original contribution
A lower solubility recommends the use of desflurane more than isoflurane, halothane, and enflurane under low-flow conditions

https://doi.org/10.1016/0952-8180(94)00003-MGet rights and content

Abstract

Study Objective: To determine whether the lower solubility of desflurane, over that of isoflurane, enflurane, and halothane, favors its use in low-flow anesthesia.

Design: Prospective clinical study.

Setting: Technical University of Munich.

Patients: 40 elderly (≥65 yrs), ASA physical status II and III surgical patients.

Interventions: All patients were anesthetized and received delivered concentrations (FD) of 4% desflurane, 1.5% isoflurane, 1.8% enflurane, or 0.9% halothane (n = 10 patients for each anesthetic) in a fresh gas inflow of 3 L/min (high-flow), until end-tidal target concentrations (FA of 2% desflurane, 0.5% isoflurane, 0.6% enflurane, and 0.3 % halothane were obtained. After 30 minutes, the inflow was decreased to 1 L/min (low-flow), and the FD and the inspired concentration (FI) were adjusted to maintain the target concentration.

Measurements and Main Results: The concentrations of the halogenated anesthetics, as well as nitrous oxide, oxygen (O2), and carbon dioxide, were measured in delivered gas at the common gas outlet and at the endotracheal tube connector. Transcutaneous O2 saturation, noninvasive blood pressure, and heart rate were also measured. During the first 30 minutes of high-flow administration, the target concentration was attained sooner with desflurane than with isoflurane, enflurane, or halothane (median levels: 4 min vs. 6 min, 8 min, or 10 min; p < 0.01). After the reduction of inflow to 1 L/min, FD had to be materially increased to maintain FI and FA for the more soluble anesthetics, but not for desflurane.

Conclusions: At low flows, FD provides a reasonable surrogate of FI and FA for desflurane, but not for isoflurane, enflurane, or halothane. The rapid and predictable titrability of desflurane favors its safe use in low-flow technique.

References (11)

  • RM Jones

    Desflurane and sevoflurane: inhalation anaesthetics for this decade?

    Br J Anaesth

    (1990)
  • N Yasuda et al.

    Solubility of I-653, sevoflurane, isoflurane, and halothane in human tissues

    Anesth Analg

    (1989)
  • SH Lockhart et al.

    Cerebral uptake and elimination of desflurane, isoflurane, and halothane from rabbit brain: an in vivo NMR study

    Anesthesiology

    (1991)
  • N Yasuda et al.

    Kinetics of desflurane, isoflurane, and halothane in humans

    Anesthesiology

    (1991)
  • EI Eger

    Stability of I-653 in soda lime

    Anesth Analg

    (1987)
There are more references available in the full text version of this article.

Cited by (0)

Supported in part by Anaquest, Inc., Liberty Corner, NJ. Presented in part at the 10th World Congress of Anesthesiologists, The Hague, June 15–19, 1992, and the German National Meeting, Deutscher Anasthesiekongress, Berlin, September 26–30, 1992.

Assistant Professor.

Resident.

§

Professor.

View full text